Robinhood NFL Prediction Markets Launch

Robinhood NFL prediction markets launched Dec 16, 2025 with parlay and prop contracts and may shift retail flow and options positioning toward sports bets.

December 17, 2025·2 min read
View all news articles
Phone merging with football helmet on violet-mist background, evoking Robinhood NFL prediction markets and sportsbook rivalry

KEY TAKEAWAYS

  • Robinhood launched NFL prediction markets adding parlay and prop contracts.
  • CEO Vlad Tenev said the expansion puts Robinhood in direct competition with sportsbooks.
  • Contracts trade nearly 24 hours with a daily pause from 3:00 to 3:15 a.m. ET.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Robinhood (HOOD) launched NFL prediction markets on Dec. 16, 2025, introducing contracts that allow users to trade on player performance and game outcomes. CEO Vlad Tenev said this move positions the company to compete with sportsbooks and could mark the start of a prediction-markets supercycle.

NFL Contracts and Trading

The new contracts enable trading on NFL game results, individual player performances through prop bets, and preset parlay bets that combine multiple outcomes. These contracts are available on Robinhood’s prediction markets platform. One example covers the New York Jets at the New Orleans Saints game scheduled for Dec. 21, 2025.

Trading runs around the clock with a daily pause from 3:00 to 3:15 a.m. ET. This near-continuous trading window aims to broaden access for retail traders and is likely to influence intraday liquidity and pricing behavior on the platform.

Positioning Against Sportsbooks

Robinhood’s management framed the expansion as a direct challenge to traditional sportsbooks. Tenev described the launch as potentially disruptive to their businesses and said it offers users another way to convert sports knowledge into investing opportunities.

He also characterized the rollout as part of a broader strategic bet on prediction markets, suggesting it could trigger a supercycle in the sector. No regulatory filings or government approvals related to the launch were identified in available reports.

The product’s combination of prop bets, parlay bets, and near-constant trading aligns Robinhood’s prediction markets with behaviors common to both trading and sports wagering, aiming to expand retail engagement.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Netflix Earnings Send NFLX Stock Lower

Netflix Earnings Send NFLX Stock Lower

Netflix earnings for Q1 2026 beat forecasts but weak Q2 guidance and Reed Hastings' planned June exit pushed shares lower in after-hours trading.

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos limited Glasswing rollout to banks prompted regulator scrutiny and raised cyber and operational risk, complicating bank positioning.

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines liquidation risk rises as jet fuel may exceed year-end cash, prompting creditors' doubts and forcing traders to reassess credit exposure.

AMD Stock Rises on Bernstein Raise and AI Demand

AMD Stock Rises on Bernstein Raise and AI Demand

AMD stock rose after Bernstein raised its 12-month target as record EPYC and MI300 data-center demand boosted flows ahead of May 5 Q1 2026 earnings.

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 went general; pricing stayed unchanged and Mythos stayed gated, a setup that could shift cloud AI costs and investor positioning.

Abbott Earnings Beat After Exact Sciences Deal

Abbott Earnings Beat After Exact Sciences Deal

Abbott earnings posted revenue and adjusted-profit beats but narrowed FY EPS guidance after the Exact Sciences acquisition, likely pressuring shares.